Identification of Circulating Long Noncoding RNA Linc00152 as a Novel Biomarker for Diagnosis and Monitoring of Non-Small-Cell Lung Cancer

<div>(a-b) ROC curve for distinguishing NSCLC patients from healthy controls (a) or benign lung disease patients (b). (c-d) ROC curves to compare the diagnostic performance of Linc00152, CEA, and a combination of Linc00152 and CEA to discriminate all NSCLC patients (c) or early stage NSCLC patients (d) from healthy controls.</div>

Disease Markers

fig4

Figure 4

Figure 4: Identification of Circulating Long Noncoding RNA Linc00152 as a Novel Biomarker for Diagnosis and Monitoring of Non-Small-Cell Lung Cancer 